Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: Phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma Article

cited authors

  • Alatrash, G; Hutson, TE; Molto, L; Richmond, A; Nemec, C; Mekhail, T; Elson, P; Tannenbaum, C; Olencki, T; Finke, J; Bukowski, RM

authors

Publication Date

  • July 15, 2004

webpage

published in

category

start page

  • 2891

end page

  • 2900

volume

  • 22

issue

  • 14